Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Alimera Sciences to Report Fourth Quarter and Full Year 2017 Results on February 28, 2018 | ||
By: Nasdaq / GlobeNewswire - 14 Feb 2018 | Back to overview list |
|
ATLANTA, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2017, after the close of the financial markets on Wednesday, February 28, 2018. An accompanying conference call will be hosted by Dan Myers, Chief Executive Officer and Rick Eiswirth, President and Chief Financial Officer to discuss the results. The call will be held at 9:00 AM ET, on Thursday, March 1, 2018. Please refer to the information below for conference call dial-in information and webcast registration. Conference Details About Alimera Sciences
For press inquiries: For investor inquiries: |
||
|
||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |